Recordati Industria Chimica e Farmaceutica (RCDTF) News Today → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free RCDTF Stock Alerts $51.60 0.00 (0.00%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 8, 2024 | markets.businessinsider.comHere's what to expect from Recordati Industria Chimica e Farmaceutica SPAAz Post raggruppamento's earningsApril 24, 2024 | msn.comBorsa: Milano fiacca con Recordati e Saipem, vola StmApril 23, 2024 | msn.comCVC explores options for Italy's Recordati, Bloomberg News reportsApril 23, 2024 | finance.yahoo.comCVC Explores Options for €11 Billion Drugmaker RecordatiApril 23, 2024 | finance.yahoo.comUPDATE 1-CVC explores options for Italy's Recordati, Bloomberg News reportsMarch 19, 2024 | msn.comFarmaceutica, le big si muovono: Astrazeneca acquista, Pfizer vende. Da Recordati cedola maggiorata con un occhio alle opportunitàDecember 29, 2023 | msn.comBorsa Milano, lieve rialzo (+0,07%), Recordati e banche in rialzoDecember 19, 2023 | seekingalpha.comRICFY Recordati Industria Chimica e Farmaceutica S.p.A.November 7, 2023 | msn.comItaly's Recordati sees 2023 results at top end of the rangeNovember 7, 2023 | uk.news.yahoo.comItaly's Recordati nudges up 2023 guidance as 9-mth revenue, profit jumpsSeptember 9, 2023 | forbes.comFondo pensione: cos’è e come funzionaJuly 21, 2023 | msn.comBorsa: Milano positiva con le banche, vola RecordatiMay 12, 2023 | msn.comItaly's Recordati boosted by strong sales in RussiaMay 11, 2023 | msn.comRecordati GAAP EPS of €0.59, revenue of €551.4MMay 11, 2023 | msn.comRecordati ups guidance on strong growth in specialty, primary care marketsApril 21, 2023 | msn.comRecordati, nel primo trimestre ricavi per 551,4 milioni di euro (+31,5%). Ok dei soci al buy back da massimi 200 milioniFebruary 21, 2023 | reuters.comRecordati shares fall after core profit margin forecasts disappointFebruary 17, 2023 | msn.comRecordati bocciata da Barclays. Che taglia il prezzo obiettivo da 40 a 35 euroJanuary 23, 2023 | reuters.comRECItah.MIJanuary 14, 2023 | businesswire.comCresce l'espansione di AESARA Europe con la nomina di Patrizia Berto, una veterana dell'industria farmaceutica italianaNovember 8, 2022 | msn.comRecordati alza la guidance per il 2022. Acconto del dividendo pari a 0,55 euroOctober 28, 2022 | finanznachrichten.deSherwin-Williams To Buy Italian Wood Coatings Firm Industria Chimica AdriaticaSeptember 27, 2022 | finance.yahoo.comRecordati Industria Chimica e Farmaceutica S.p.A. (0KBS.L)September 18, 2022 | finance.yahoo.comRecordati Industria Chimica e Farmaceutica S.p.A. (REC.VI)September 8, 2022 | finance.yahoo.comRecordati Industria Chimica e Farmaceutica S.p.A. (REC.MI)August 31, 2022 | finance.yahoo.comRecordati Rare Diseases Announce Publication of Long-term Outcomes From the Extension to the Phase III LINC 3 Study of Isturisa® (Osilodrostat) in Patients With Cushing’s Disease in the European Journal of EndocrinologyJuly 30, 2022 | seekingalpha.comRecordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Robert Koremans on Q2 2022 Results - Earnings Call TranscriptJune 16, 2022 | apnews.comRecordati Rare Diseases Announces Positive Data From Phase III Linc 4, Phase III Linc 3, and Illustrate ISTURISA® Studies Presented at ENDO 2022June 8, 2022 | finance.yahoo.comRecordati Rare Diseases Announces Several Scientific Abstracts to Be Presented at the Upcoming Endo Society Annual MeetingMay 14, 2022 | seekingalpha.comRecordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Robert Koremans on Q1 2022 Results - Earnings Call TranscriptMay 10, 2022 | uk.news.yahoo.comRecordati confirms 2022 targets despite Ukraine conflictMay 10, 2022 | finance.yahoo.comRecordati Rare Diseases Announces Multiple Scientific Abstracts to Be Highlighted at American Association of Clinical EndocrinologyMarch 29, 2022 | finance.yahoo.comRecordati Rare Diseases Announce Publication in the Journal of Clinical Endocrinology & Metabolism of the Phase III LINC 4 Study Confirming the Efficacy and Safety of Isturisa® (Osilodrostat) in Patients With Cushing’s DiseaseFebruary 26, 2022 | it.investing.comRecordati manca previsioni degli analistiFebruary 25, 2022 | seekingalpha.comRecordati reports FY resultsFebruary 24, 2022 | msn.comRecordati, per ora non grandi impatti da invasione russa in UcrainaFebruary 24, 2022 | msn.comRecordati cresce nel 2021, ma la redditività è sotto le atteseDecember 21, 2021 | msn.comMilano, in piazza Affari nessuno come il colosso RecordatiDecember 3, 2021 | msn.comRecordati, shopping in Gran Bretagna: accordo da 750 milioni per Eusa PharmaDecember 3, 2021 | nasdaq.comRecordati to buy EUSA Pharma for $847 mln to boost rare disease offeringDecember 3, 2021 | ft.comCVC-controlled Recordati buys UK start-up to expand rare cancers portfolioNovember 26, 2021 | finance.yahoo.comKKR, CVC Are Said to Weigh Teaming Up on Telecom Italia BidAugust 25, 2021 | businesswire.comRecordati Rare Diseases Announces William Ludlam, MD, PhD, As New Chief Medical Officer and Vice President - Clinical Development Get Recordati Industria Chimica e Farmaceutica News Delivered to You Automatically Sign up to receive the latest news and ratings for RCDTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Amazon's betting big on this unknown AI company (Ad)Amazon's Betting Big on This Unknown AI Company Amazon has just made a stunning $144 million investment in one small AI company. Discover why this company RCDTF Media Mentions By Week RCDTF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCDTF News Sentiment▼0.340.54▲Average Medical News Sentiment RCDTF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCDTF Articles This Week▼00▲RCDTF Articles Average Week Get Recordati Industria Chimica e Farmaceutica News Delivered to You Automatically Sign up to receive the latest news and ratings for RCDTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sysmex News Eurofins Scientific News Sonic Healthcare News Amplifon News Shionogi & Co., Ltd. News Sandoz Group News Aurora Cannabis News Sino Biopharmaceutical News Aspen Pharmacare News Hikma Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RCDTF) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressAmazon's betting big on this unknown AI companyManward PressWall Street legend who predicted 2021 tech crash issues new warningChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recordati Industria Chimica e Farmaceutica S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
